A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new ...
Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for ...
Peter Thiel-backed Lindus Health has raised $55 million as it sets about "fixing the broken clinical trial industry." ...
Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.
Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.
AI is rapidly advancing, with significant strides being made toward achieving more powerful and capable systems.
Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...
The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to ...
An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.
With each new year comes a new set of accompanying challenges, from tackling the latest innovations to new incarnations of old issues. 2025 will be ...
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...